Skip to main content
logo
ODI Pharma AB (publ) (NGM:ODI)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.260
-0.080 (-3.42%)
At close: Sep 3, 2026

ODI Pharma AB Financials Overview

Millions SEK. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
32.9232.923.1322.290.140.31
Revenue Growth
950.33%950.33%-85.94%15880.34%-55.44%-
Gross Profit
10.2710.270.844.62-0.72-0.1
Operating Income
2.52.5-5.450.43-6.81-7.21
Net Income
1.991.99-5.93-0.57-6.9-7.24
Earnings Per Share
0.110.11-0.32-0.04-0.45-0.48
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
3.393.391.482.646.497.36
Net Cash Growth
128.28%128.28%-43.87%-59.28%-11.76%-49.69%
Net Cash Per Share
0.180.180.080.170.420.49
Cash & Investments
3.393.391.482.646.497.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
4.584.58-3.31-3.82-5.1-7.37
Capital Expenditures
------0
Free Cash Flow
4.584.58-3.31-3.82-5.1-7.38
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
31.20%31.20%26.77%20.74%--33.12%
Operating Margin
7.61%7.61%-173.94%1.92%-4884.20%-2302.98%
Pretax Margin
6.04%6.04%-189.19%-1.70%-4944.26%-2312.13%
Profit Margin
6.04%6.04%-189.33%-2.55%-4948.58%-2313.25%
FCF Margin
13.90%13.90%-105.49%-17.16%-3659.83%-2357.80%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
20.8422.13----
P/FCF Ratio
9.059.61----
PS Ratio
1.261.3411.074.92600.26262.63